Margaret Bigwood Pulsifer, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 13 | 2024 | 914 | 1.280 |
Why?
|
| Medulloblastoma | 8 | 2021 | 682 | 1.130 |
Why?
|
| Brain Neoplasms | 12 | 2024 | 9182 | 1.010 |
Why?
|
| Executive Function | 4 | 2024 | 1402 | 0.960 |
Why?
|
| Intelligence | 12 | 2020 | 929 | 0.940 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 3 | 2024 | 495 | 0.860 |
Why?
|
| Cerebellar Neoplasms | 5 | 2021 | 590 | 0.780 |
Why?
|
| Implantable Neurostimulators | 2 | 2021 | 75 | 0.760 |
Why?
|
| Mutism | 1 | 2019 | 27 | 0.660 |
Why?
|
| Cognition | 14 | 2024 | 7066 | 0.660 |
Why?
|
| Tuberous Sclerosis | 8 | 2013 | 1040 | 0.640 |
Why?
|
| Electric Stimulation Therapy | 2 | 2021 | 636 | 0.610 |
Why?
|
| Neuropsychological Tests | 16 | 2024 | 7134 | 0.520 |
Why?
|
| Cognition Disorders | 9 | 2021 | 3985 | 0.490 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2022 | 1890 | 0.450 |
Why?
|
| Psychological Tests | 2 | 2007 | 643 | 0.410 |
Why?
|
| Child Behavior Disorders | 3 | 2008 | 813 | 0.380 |
Why?
|
| Child | 40 | 2024 | 80863 | 0.370 |
Why?
|
| Memory Disorders | 1 | 2018 | 1204 | 0.360 |
Why?
|
| Hypoglossal Nerve | 2 | 2021 | 109 | 0.340 |
Why?
|
| Child, Preschool | 33 | 2024 | 42623 | 0.330 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2007 | 2538 | 0.290 |
Why?
|
| Adolescent | 32 | 2024 | 89168 | 0.280 |
Why?
|
| Telemedicine | 2 | 2021 | 3104 | 0.280 |
Why?
|
| Hippocampus | 3 | 2018 | 3783 | 0.270 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 928 | 0.270 |
Why?
|
| Analysis of Variance | 5 | 2018 | 6242 | 0.250 |
Why?
|
| Child Development | 4 | 2003 | 2328 | 0.240 |
Why?
|
| Cocaine | 3 | 2007 | 960 | 0.240 |
Why?
|
| Neuropil | 1 | 2024 | 31 | 0.230 |
Why?
|
| Neuropsychology | 2 | 2021 | 110 | 0.220 |
Why?
|
| Hemispherectomy | 1 | 2004 | 41 | 0.220 |
Why?
|
| Quality of Life | 6 | 2022 | 13497 | 0.220 |
Why?
|
| Ependymoma | 2 | 2018 | 324 | 0.210 |
Why?
|
| Wechsler Scales | 2 | 2018 | 258 | 0.200 |
Why?
|
| Cochlear Implants | 2 | 2004 | 343 | 0.200 |
Why?
|
| Young Adult | 17 | 2024 | 60045 | 0.200 |
Why?
|
| Speech Perception | 2 | 2004 | 512 | 0.190 |
Why?
|
| Ketone Bodies | 1 | 2001 | 76 | 0.190 |
Why?
|
| Presenilins | 1 | 2021 | 53 | 0.190 |
Why?
|
| Alzheimer Disease | 5 | 2024 | 8721 | 0.180 |
Why?
|
| Male | 50 | 2024 | 364781 | 0.180 |
Why?
|
| Female | 49 | 2024 | 396943 | 0.180 |
Why?
|
| Motor Skills | 3 | 2020 | 522 | 0.180 |
Why?
|
| Memory, Short-Term | 2 | 2017 | 1009 | 0.170 |
Why?
|
| Child Behavior | 3 | 2003 | 862 | 0.170 |
Why?
|
| Protons | 3 | 2021 | 1113 | 0.170 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2020 | 783 | 0.160 |
Why?
|
| Parents | 5 | 2018 | 3596 | 0.160 |
Why?
|
| Craniopharyngioma | 2 | 2021 | 279 | 0.160 |
Why?
|
| Dementia | 5 | 2024 | 2723 | 0.160 |
Why?
|
| Language Development Disorders | 1 | 2020 | 193 | 0.150 |
Why?
|
| Postoperative Period | 2 | 2019 | 1833 | 0.150 |
Why?
|
| Intelligence Tests | 3 | 2011 | 505 | 0.150 |
Why?
|
| Humans | 64 | 2024 | 768451 | 0.150 |
Why?
|
| Organs at Risk | 2 | 2018 | 368 | 0.150 |
Why?
|
| Cranial Irradiation | 2 | 2018 | 395 | 0.140 |
Why?
|
| Cerebellar Diseases | 1 | 2019 | 221 | 0.140 |
Why?
|
| Functional Laterality | 1 | 2004 | 2268 | 0.140 |
Why?
|
| Treatment Outcome | 16 | 2022 | 65409 | 0.140 |
Why?
|
| Mental Disorders | 4 | 2017 | 6879 | 0.130 |
Why?
|
| Epilepsy | 4 | 2012 | 3324 | 0.130 |
Why?
|
| Inositol | 1 | 2017 | 216 | 0.130 |
Why?
|
| Schools | 1 | 2004 | 1496 | 0.120 |
Why?
|
| Cerebellum | 2 | 2019 | 1515 | 0.120 |
Why?
|
| Developmental Disabilities | 3 | 2001 | 1516 | 0.120 |
Why?
|
| Stress, Psychological | 2 | 2008 | 4538 | 0.120 |
Why?
|
| Glioma | 3 | 2018 | 3523 | 0.120 |
Why?
|
| Longevity | 1 | 2021 | 1077 | 0.110 |
Why?
|
| Vaccines | 1 | 2022 | 845 | 0.110 |
Why?
|
| Military Personnel | 1 | 2002 | 1264 | 0.110 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15965 | 0.100 |
Why?
|
| Adult | 26 | 2024 | 223542 | 0.100 |
Why?
|
| Radiometry | 1 | 2018 | 816 | 0.100 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2013 | 137 | 0.100 |
Why?
|
| Pituitary Neoplasms | 1 | 2021 | 1325 | 0.100 |
Why?
|
| Supratentorial Neoplasms | 1 | 2013 | 159 | 0.100 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 263 | 0.100 |
Why?
|
| Age Factors | 8 | 2018 | 18478 | 0.100 |
Why?
|
| Infant | 13 | 2021 | 36497 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 1315 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2007 | 3837 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2021 | 8730 | 0.090 |
Why?
|
| Seizures | 2 | 2001 | 2996 | 0.090 |
Why?
|
| Photons | 1 | 2014 | 595 | 0.090 |
Why?
|
| Prospective Studies | 9 | 2022 | 54914 | 0.090 |
Why?
|
| Social Adjustment | 1 | 2012 | 636 | 0.090 |
Why?
|
| Comprehension | 1 | 2015 | 641 | 0.080 |
Why?
|
| Adaptation, Psychological | 2 | 2011 | 2665 | 0.080 |
Why?
|
| Longitudinal Studies | 5 | 2020 | 14766 | 0.080 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 1680 | 0.080 |
Why?
|
| Mothers | 2 | 2001 | 2210 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2024 | 41797 | 0.080 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 39430 | 0.080 |
Why?
|
| Memory | 1 | 2018 | 2210 | 0.070 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 26351 | 0.070 |
Why?
|
| Autistic Disorder | 2 | 2012 | 1240 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2011 | 600 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 953 | 0.070 |
Why?
|
| Retrospective Studies | 13 | 2024 | 81834 | 0.070 |
Why?
|
| Phenotype | 4 | 2015 | 16712 | 0.060 |
Why?
|
| Age of Onset | 4 | 2021 | 3342 | 0.060 |
Why?
|
| Radiotherapy | 1 | 2012 | 1510 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15460 | 0.060 |
Why?
|
| Cochlear Aqueduct | 1 | 2004 | 7 | 0.060 |
Why?
|
| Encephalitis | 2 | 1999 | 441 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 2819 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8753 | 0.060 |
Why?
|
| Maternal Age | 1 | 2007 | 809 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 775 | 0.050 |
Why?
|
| Radiotherapy Dosage | 3 | 2016 | 2925 | 0.050 |
Why?
|
| Pediatrics | 1 | 2018 | 3622 | 0.050 |
Why?
|
| Meningitis | 1 | 2004 | 219 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2427 | 0.050 |
Why?
|
| Community Health Nursing | 1 | 2001 | 23 | 0.050 |
Why?
|
| Psychomotor Performance | 3 | 2007 | 1894 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2017 | 6035 | 0.050 |
Why?
|
| Brain | 6 | 2019 | 27438 | 0.050 |
Why?
|
| Emotions | 2 | 2015 | 2773 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 2013 | 5827 | 0.050 |
Why?
|
| Colombia | 1 | 2021 | 285 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2017 | 36840 | 0.040 |
Why?
|
| Germinoma | 1 | 2021 | 132 | 0.040 |
Why?
|
| Attention | 3 | 2015 | 2423 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 1514 | 0.040 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2020 | 210 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 18048 | 0.040 |
Why?
|
| Narcotics | 1 | 2001 | 337 | 0.040 |
Why?
|
| Cochlear Implantation | 1 | 2003 | 319 | 0.040 |
Why?
|
| Pregnancy | 6 | 2007 | 30179 | 0.040 |
Why?
|
| Nausea | 1 | 2021 | 682 | 0.040 |
Why?
|
| Patient Participation | 1 | 2007 | 1450 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2002 | 1337 | 0.040 |
Why?
|
| Vomiting | 1 | 2021 | 655 | 0.040 |
Why?
|
| Moyamoya Disease | 1 | 2021 | 274 | 0.040 |
Why?
|
| Middle Aged | 13 | 2024 | 223418 | 0.040 |
Why?
|
| Fragile X Syndrome | 1 | 1998 | 116 | 0.030 |
Why?
|
| Rett Syndrome | 1 | 1998 | 164 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2007 | 1439 | 0.030 |
Why?
|
| Family | 1 | 2007 | 3208 | 0.030 |
Why?
|
| Behavioral Symptoms | 1 | 1998 | 188 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2003 | 1078 | 0.030 |
Why?
|
| Survivors | 2 | 2018 | 2381 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2022 | 12450 | 0.030 |
Why?
|
| Parenting | 1 | 2001 | 707 | 0.030 |
Why?
|
| Auditory Perception | 1 | 2020 | 588 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1909 | 0.030 |
Why?
|
| Sex Factors | 2 | 2021 | 10647 | 0.030 |
Why?
|
| Aged | 3 | 2024 | 171520 | 0.030 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 806 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 6856 | 0.030 |
Why?
|
| Social Behavior | 1 | 2001 | 1144 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 4052 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2656 | 0.030 |
Why?
|
| Substance-Related Disorders | 3 | 2003 | 4453 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 2014 | 91 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 1997 | 555 | 0.030 |
Why?
|
| Fatigue | 1 | 2021 | 1556 | 0.030 |
Why?
|
| Vision Disorders | 1 | 2021 | 1092 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 2021 | 1205 | 0.030 |
Why?
|
| Urban Population | 1 | 2001 | 2047 | 0.030 |
Why?
|
| Language Tests | 1 | 1993 | 193 | 0.030 |
Why?
|
| Decision Making | 1 | 2007 | 3961 | 0.030 |
Why?
|
| Headache | 1 | 2021 | 1260 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 2014 | 634 | 0.020 |
Why?
|
| Amygdala | 1 | 1999 | 1382 | 0.020 |
Why?
|
| Radiotherapy, Conformal | 1 | 2014 | 549 | 0.020 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 250 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 1996 | 1461 | 0.020 |
Why?
|
| Speech | 1 | 2015 | 558 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 4572 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2016 | 2932 | 0.020 |
Why?
|
| Language | 1 | 1999 | 1557 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5308 | 0.020 |
Why?
|
| Disease Progression | 2 | 2020 | 13655 | 0.020 |
Why?
|
| Baltimore | 2 | 2001 | 234 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 20231 | 0.020 |
Why?
|
| Genotype | 2 | 2015 | 13047 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 4041 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 3891 | 0.020 |
Why?
|
| Motor Activity | 1 | 1998 | 2722 | 0.020 |
Why?
|
| Asthma | 1 | 2007 | 6274 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3637 | 0.020 |
Why?
|
| Role Playing | 1 | 2007 | 21 | 0.020 |
Why?
|
| Paternalism | 1 | 2007 | 49 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1568 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 2007 | 106 | 0.020 |
Why?
|
| Nurse-Patient Relations | 1 | 2007 | 100 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2014 | 1728 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2013 | 1348 | 0.020 |
Why?
|
| Audiovisual Aids | 1 | 2007 | 99 | 0.020 |
Why?
|
| Pediatric Nursing | 1 | 2007 | 104 | 0.020 |
Why?
|
| Penetrance | 1 | 2007 | 384 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2007 | 472 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2007 | 447 | 0.020 |
Why?
|
| Mental Competency | 1 | 2007 | 179 | 0.020 |
Why?
|
| Electroencephalography | 2 | 2011 | 6309 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6537 | 0.020 |
Why?
|
| Social Support | 1 | 2015 | 2195 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3550 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1997 | 13026 | 0.010 |
Why?
|
| Speech Intelligibility | 1 | 2004 | 80 | 0.010 |
Why?
|
| Population Surveillance | 1 | 1994 | 2601 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2017 | 6410 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 4120 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10125 | 0.010 |
Why?
|
| Atrophy | 2 | 1999 | 1648 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2007 | 835 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2007 | 651 | 0.010 |
Why?
|
| Cause of Death | 1 | 2013 | 3727 | 0.010 |
Why?
|
| Self Care | 1 | 2007 | 798 | 0.010 |
Why?
|
| Infant, Newborn | 4 | 2007 | 26395 | 0.010 |
Why?
|
| Observer Variation | 1 | 2007 | 2622 | 0.010 |
Why?
|
| Prognosis | 2 | 2016 | 30028 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11249 | 0.010 |
Why?
|
| Education | 1 | 2003 | 536 | 0.010 |
Why?
|
| Pedigree | 1 | 2007 | 4545 | 0.010 |
Why?
|
| Personality Assessment | 1 | 2001 | 649 | 0.010 |
Why?
|
| Crack Cocaine | 1 | 1998 | 33 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 2001 | 418 | 0.010 |
Why?
|
| Body Constitution | 1 | 1998 | 273 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14728 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 2339 | 0.010 |
Why?
|
| Sturge-Weber Syndrome | 1 | 1997 | 89 | 0.010 |
Why?
|
| Cocaine-Related Disorders | 1 | 1999 | 461 | 0.010 |
Why?
|
| Locomotion | 1 | 1998 | 391 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2016 | 24311 | 0.010 |
Why?
|
| Marijuana Abuse | 1 | 1998 | 412 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40271 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 2863 | 0.010 |
Why?
|
| Communication | 1 | 2007 | 3910 | 0.010 |
Why?
|
| Home Care Services | 1 | 1999 | 655 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2007 | 6610 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 3438 | 0.010 |
Why?
|
| Movement | 1 | 1998 | 1489 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 1629 | 0.010 |
Why?
|
| Walking | 1 | 1998 | 1202 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 1487 | 0.010 |
Why?
|
| Gestational Age | 1 | 1999 | 3615 | 0.010 |
Why?
|
| Birth Weight | 1 | 1998 | 2117 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 4941 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 1998 | 22293 | 0.010 |
Why?
|
| Cost of Illness | 1 | 1997 | 1960 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1999 | 9687 | 0.000 |
Why?
|
| Comorbidity | 1 | 1999 | 10601 | 0.000 |
Why?
|
| Logistic Models | 1 | 1999 | 13324 | 0.000 |
Why?
|
| Risk Factors | 1 | 2011 | 74915 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 59680 | 0.000 |
Why?
|
| Mutation | 1 | 2007 | 30243 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1997 | 6740 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1993 | 12096 | 0.000 |
Why?
|
| Aging | 1 | 1997 | 8761 | 0.000 |
Why?
|